These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 27010239)

  • 1. DNMT3A R882 mutants interact with polycomb proteins to block haematopoietic stem and leukaemic cell differentiation.
    Koya J; Kataoka K; Sato T; Bando M; Kato Y; Tsuruta-Kishino T; Kobayashi H; Narukawa K; Miyoshi H; Shirahige K; Kurokawa M
    Nat Commun; 2016 Mar; 7():10924. PubMed ID: 27010239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Functional role of DNMT3A mutation in acute myeloid leukemia].
    Koya J; Kurokawa M
    Rinsho Ketsueki; 2018; 59(5):602-610. PubMed ID: 29877252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia.
    Rau RE; Rodriguez BA; Luo M; Jeong M; Rosen A; Rogers JH; Campbell CT; Daigle SR; Deng L; Song Y; Sweet S; Chevassut T; Andreeff M; Kornblau SM; Li W; Goodell MA
    Blood; 2016 Aug; 128(7):971-81. PubMed ID: 27335278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia.
    Shlush LI; Zandi S; Mitchell A; Chen WC; Brandwein JM; Gupta V; Kennedy JA; Schimmer AD; Schuh AC; Yee KW; McLeod JL; Doedens M; Medeiros JJ; Marke R; Kim HJ; Lee K; McPherson JD; Hudson TJ; ; Brown AM; Yousif F; Trinh QM; Stein LD; Minden MD; Wang JC; Dick JE
    Nature; 2014 Feb; 506(7488):328-33. PubMed ID: 24522528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML Progression.
    Spencer DH; Russler-Germain DA; Ketkar S; Helton NM; Lamprecht TL; Fulton RS; Fronick CC; O'Laughlin M; Heath SE; Shinawi M; Westervelt P; Payton JE; Wartman LD; Welch JS; Wilson RK; Walter MJ; Link DC; DiPersio JF; Ley TJ
    Cell; 2017 Feb; 168(5):801-816.e13. PubMed ID: 28215704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and Epigenetic Perturbations by DNMT3A-R882 Mutants Impaired Apoptosis through Augmentation of PRDX2 in Myeloid Leukemia Cells.
    Bera R; Chiu MC; Huang YJ; Liang DC; Lee YS; Shih LY
    Neoplasia; 2018 Nov; 20(11):1106-1120. PubMed ID: 30245403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haploinsufficiency for DNA methyltransferase 3A predisposes hematopoietic cells to myeloid malignancies.
    Cole CB; Russler-Germain DA; Ketkar S; Verdoni AM; Smith AM; Bangert CV; Helton NM; Guo M; Klco JM; O'Laughlin S; Fronick C; Fulton R; Chang GS; Petti AA; Miller CA; Ley TJ
    J Clin Invest; 2017 Oct; 127(10):3657-3674. PubMed ID: 28872462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two competing mechanisms of DNMT3A recruitment regulate the dynamics of de novo DNA methylation at PRC1-targeted CpG islands.
    Weinberg DN; Rosenbaum P; Chen X; Barrows D; Horth C; Marunde MR; Popova IK; Gillespie ZB; Keogh MC; Lu C; Majewski J; Allis CD
    Nat Genet; 2021 Jun; 53(6):794-800. PubMed ID: 33986537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enforced differentiation of Dnmt3a-null bone marrow leads to failure with c-Kit mutations driving leukemic transformation.
    Celik H; Mallaney C; Kothari A; Ostrander EL; Eultgen E; Martens A; Miller CA; Hundal J; Klco JM; Challen GA
    Blood; 2015 Jan; 125(4):619-28. PubMed ID: 25416276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic Perturbations by Arg882-Mutated DNMT3A Potentiate Aberrant Stem Cell Gene-Expression Program and Acute Leukemia Development.
    Lu R; Wang P; Parton T; Zhou Y; Chrysovergis K; Rockowitz S; Chen WY; Abdel-Wahab O; Wade PA; Zheng D; Wang GG
    Cancer Cell; 2016 Jul; 30(1):92-107. PubMed ID: 27344947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo DNA methyltransferase is essential for self-renewal, but not for differentiation, in hematopoietic stem cells.
    Tadokoro Y; Ema H; Okano M; Li E; Nakauchi H
    J Exp Med; 2007 Apr; 204(4):715-22. PubMed ID: 17420264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dnmt3a is essential for hematopoietic stem cell differentiation.
    Challen GA; Sun D; Jeong M; Luo M; Jelinek J; Berg JS; Bock C; Vasanthakumar A; Gu H; Xi Y; Liang S; Lu Y; Darlington GJ; Meissner A; Issa JP; Godley LA; Li W; Goodell MA
    Nat Genet; 2011 Dec; 44(1):23-31. PubMed ID: 22138693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of Dnmt3a and endogenous Kras(G12D/+) cooperate to regulate hematopoietic stem and progenitor cell functions in leukemogenesis.
    Chang YI; You X; Kong G; Ranheim EA; Wang J; Du J; Liu Y; Zhou Y; Ryu MJ; Zhang J
    Leukemia; 2015 Sep; 29(9):1847-56. PubMed ID: 25801914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of DNMT3A mutations at long-term remission in adult patients with AML.
    Pløen GG; Nederby L; Guldberg P; Hansen M; Ebbesen LH; Jensen UB; Hokland P; Aggerholm A
    Br J Haematol; 2014 Nov; 167(4):478-86. PubMed ID: 25371149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycomb Cbx family members mediate the balance between haematopoietic stem cell self-renewal and differentiation.
    Klauke K; Radulović V; Broekhuis M; Weersing E; Zwart E; Olthof S; Ritsema M; Bruggeman S; Wu X; Helin K; Bystrykh L; de Haan G
    Nat Cell Biol; 2013 Apr; 15(4):353-62. PubMed ID: 23502315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of hematopoietic stem cells using protein transduction domain-fused Polycomb.
    Kajiume T; Sera Y; Kawahara Y; Matsumoto M; Fukazawa T; Imura T; Yuge L; Kobayashi M
    Exp Hematol; 2012 Sep; 40(9):751-760.e1. PubMed ID: 22634509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic Guardian: A Review of the DNA Methyltransferase DNMT3A in Acute Myeloid Leukaemia and Clonal Haematopoiesis.
    Chaudry SF; Chevassut TJ
    Biomed Res Int; 2017; 2017():5473197. PubMed ID: 28286768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of three novel DNMT3A mutations with compromising methylation capacity in human acute myeloid leukaemia.
    Ali AM; Salih GF
    Mol Biol Rep; 2022 Dec; 49(12):11685-11693. PubMed ID: 36175738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two novel methods for rapid detection and quantification of DNMT3A R882 mutations in acute myeloid leukemia.
    Mancini M; Hasan SK; Ottone T; Lavorgna S; Ciardi C; Angelini DF; Agostini F; Venditti A; Lo-Coco F
    J Mol Diagn; 2015 Mar; 17(2):179-84. PubMed ID: 25554589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNMT3A(R882H) mutant and Tet2 inactivation cooperate in the deregulation of DNA methylation control to induce lymphoid malignancies in mice.
    Scourzic L; Couronné L; Pedersen MT; Della Valle V; Diop M; Mylonas E; Calvo J; Mouly E; Lopez CK; Martin N; Fontenay M; Bender A; Guibert S; Dubreuil P; Dessen P; Droin N; Pflumio F; Weber M; Gaulard P; Helin K; Mercher T; Bernard OA
    Leukemia; 2016 Jun; 30(6):1388-98. PubMed ID: 26876596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.